Location History:
- San Francisco, CA (US) (2003)
- Foster City, CA (US) (2005)
Company Filing History:
Years Active: 2003-2005
Title: Eva Chan: Innovator in Cell Cycle Research
Introduction
Eva Chan is a prominent inventor based in San Francisco, CA (US). She has made significant contributions to the field of cell cycle research, holding a total of 3 patents. Her work focuses on novel polypeptides and nucleic acids that have implications for understanding and manipulating the cell cycle.
Latest Patents
One of her latest patents is titled "Tankyrase H, compositions involved in the cell cycle and methods of use." This invention is directed to novel polypeptides, nucleic acids, and related molecules that affect or are related to the cell cycle. The patent also includes vectors and host cells that comprise these nucleic acid sequences, as well as chimeric polypeptide molecules that fuse the polypeptides of the present invention to heterologous polypeptide sequences. Additionally, it covers antibodies that bind to these polypeptides and methods for producing them. Furthermore, the invention provides methods for identifying novel compositions that mediate cell cycle bioactivity, which can be utilized in the diagnosis and treatment of diseases.
Career Highlights
Eva Chan is currently employed at Rigel Pharmaceuticals, Incorporated, where she continues her research and development efforts. Her innovative work has positioned her as a key figure in her field, contributing to advancements in medical science.
Collaborations
Some of her notable coworkers include Ying Luo and Xiang Xu, who collaborate with her on various projects related to her research.
Conclusion
Eva Chan's contributions to cell cycle research through her patents and work at Rigel Pharmaceuticals highlight her role as an influential inventor in the scientific community. Her innovative approaches have the potential to lead to significant advancements in medical treatments and diagnostics.